» Articles » PMID: 34359803

Prognostic Discrimination of Alternative Lymph Node Classification Systems for Patients with Radically Resected Non-Metastatic Colorectal Cancer: A Cohort Study from a Single Tertiary Referral Center

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2021 Aug 7
PMID 34359803
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lymph node ratio (LNR) and the Log odds of positive lymph nodes (LODDS) have been proposed as a new prognostic indicator in surgical oncology. Various studies have shown a superior discriminating power of LODDS over LNR and lymph node category (N) in diverse cancer entities, when examined as a continuous variable. However, for each of the classification systems various cut-off values have been defined, with the question of the most appropriate for patients with CRC still remaining open. The present study aimed to compare the predictive impact of different lymph node classification systems and to define the best cut-off values regarding accurate evaluation of overall survival in patients with resectable, non-metastatic colorectal cancer (CRC).

Methods: CRC patients who underwent surgical resection from 1996 to 2018 were extracted from our medical data base. Cox proportional hazards regression models and C-statistics were performed to assess the discriminative power of 25 LNR and 26 LODDS classifications. Regression models were adjusted for age, sex, extent of the tumor, differentiation, tumor size and localization.

Results: Our study group consisted of 654 consecutive patients with non-metastatic CRC. C-statistic revealed 2 LNR and 5 LODDS classifications that demonstrated superior prognostic performance in patients with UICC III CRC, compared to the N category. No clear advantage of one classification over another could be demonstrated in any other patient subgroup.

Conclusions: Distinct LNR and LODDS classifications demonstrate a prognostic superiority over the N category only in patients with Stage III radically resected CRC.

Citing Articles

Survival analysis in pT1-3 and paracolic lymph-node invasion colorectal cancer: the prognostic role of positive paracolic lymph-node ratio for adjuvant chemotherapy.

Feng X, Liao W, Tang Y, Yi X, Tian T, Li H Clin Transl Oncol. 2024; 26(12):2993-3002.

PMID: 38782864 DOI: 10.1007/s12094-024-03470-z.


A survival nomogram model for patients with resectable non-small cell lung cancer and lymph node metastasis (N1 or N2) based on the Surveillance, Epidemiology, and End Results Database and single-center data.

He C, Ni M, Liu J, Teng X, Ke L, Matsuura Y Transl Lung Cancer Res. 2024; 13(3):573-586.

PMID: 38601448 PMC: 11002513. DOI: 10.21037/tlcr-24-119.


The Role of Alternative Lymph Node Classification Systems in Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NEN): Superiority of a LODDS Scheme Over N Category in Pancreatic NEN (pNEN).

Krieg S, Tunk J, Vaghiri S, Prassas D, Jann H, Mohr R Horm Metab Res. 2023; 55(7):452-461.

PMID: 37494059 PMC: 10370471. DOI: 10.1055/a-2102-7694.


Construction of a new clinical staging system for colorectal cancer based on the lymph node ratio: A validation study.

Yang Y, Wang Y, Wang Z Front Surg. 2022; 9:929576.

PMID: 36090338 PMC: 9452833. DOI: 10.3389/fsurg.2022.929576.


Comparison of Four Lymph Node Staging Systems in Gastric Adenocarcinoma after Neoadjuvant Therapy - A Population-Based Study.

Lai H, Zheng J, Li Y Front Surg. 2022; 9:918198.

PMID: 35756471 PMC: 9215688. DOI: 10.3389/fsurg.2022.918198.


References
1.
Huang B, Chen C, Ni M, Mo S, Cai G, Cai S . Log odds of positive lymph nodes is a superior prognostic indicator in stage III rectal cancer patients: A retrospective analysis of 17,632 patients in the SEER database. Int J Surg. 2016; 32:24-30. DOI: 10.1016/j.ijsu.2016.06.002. View

2.
Yang M, Zhang H, Ma Z, Gong L, Chen C, Ren P . Log odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection. J Thorac Dis. 2017; 9(5):1182-1189. PMC: 5465161. DOI: 10.21037/jtd.2017.03.187. View

3.
Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

4.
Wang J, Hassett J, Dayton M, Kulaylat M . The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer. J Gastrointest Surg. 2008; 12(10):1790-6. DOI: 10.1007/s11605-008-0651-3. View

5.
Kim J, Chung S, Choi B, Lee I, An C, Won J . Prognostic significance of the lymph node ratio regarding recurrence and survival in rectal cancer patients treated with postoperative chemoradiotherapy. Gut Liver. 2012; 6(2):203-9. PMC: 3343158. DOI: 10.5009/gnl.2012.6.2.203. View